Matthew Gubens, M.D., discussed the future of biomarker testing in non-small cell lung cancer.
Genetic testing can help survivors understand their risk of developing a second cancer, so why aren’t more having this done? By
After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.
Shana Wingo, M.D., discussed advancements being made in the field of surgery for patients with gynecologic cancers.
Improvements to radiation therapy aim to better target gynecologic tumors while sparing healthy tissue.
In the world of the Internet, consumers can purchase practically anything they wish for — except a surefire cure for cancer.
A recent study examined common co-morbidities, such as diabetes, heart disease and hypertension, and their effects on ovarian cancer survival.
Early introduction of palliative care can improve quality of life for patients with gynecologic cancers.
Letters from you, our readers.